QXO (NASDAQ:QXO – Get Free Report) is anticipated to announce its Q2 2025 earnings results before the market opens on Wednesday, August 13th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $1.87 billion for the quarter.
QXO Price Performance
NASDAQ QXO opened at $19.27 on Tuesday. The business’s 50-day simple moving average is $20.86 and its 200-day simple moving average is $16.32. The firm has a market capitalization of $11.19 billion, a P/E ratio of -2.11, a P/E/G ratio of 4.09 and a beta of 2.34. QXO has a 1-year low of $10.62 and a 1-year high of $24.69.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in QXO by 13.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 697,889 shares of the company’s stock valued at $9,449,000 after buying an additional 81,758 shares during the period. Millennium Management LLC increased its position in QXO by 6.6% in the 1st quarter. Millennium Management LLC now owns 322,115 shares of the company’s stock worth $4,361,000 after purchasing an additional 20,067 shares during the last quarter. AQR Capital Management LLC acquired a new position in QXO in the 1st quarter worth about $615,000. Finally, Royal Bank of Canada increased its position in QXO by 67.5% in the 1st quarter. Royal Bank of Canada now owns 119,688 shares of the company’s stock worth $1,620,000 after purchasing an additional 48,248 shares during the last quarter. 58.68% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Get Our Latest Analysis on QXO
QXO Company Profile
QXO, Inc operates as a business application, technology, and consulting company in North America. The company provides solutions for accounting and business management, financial reporting, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence.
See Also
- Five stocks we like better than QXO
- Top Biotech Stocks: Exploring Innovation Opportunities
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- How to Capture the Benefits of Dividend Increases
- IPO Market Stays Hot With These 2 Debuting Stocks
- How to Effectively Use the MarketBeat Ratings Screener
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for QXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QXO and related companies with MarketBeat.com's FREE daily email newsletter.